ArticleResearch and practice in thrombosis and haemostasis2026
Modeling the role of platelet-released polyphosphates in tissue factor-initiated coagulation under flow.
Article in Research and practice in thrombosis and haemostasis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Background: Activated platelets release polyphosphate (polyP), a linear polymer of inorganic phosphate residues, from dense granules. Experiments performed under no-flow conditions show that polyP alters the kinetics of tissue factor (TF) pathway reactions, accelerating factor XI (FXI) activation by thrombin and FV activation by factor Xa and thrombin, and may impact inhibition by tissue factor pathway inhibitor α (TFPIα). How polyP influences this pathway in conjunction with platelet deposition under flow remains understudied. Objectives: This study aimed to investigate how polyP-mediated acceleration of FV and FXI activation modulates thrombin generation under flow in TF-initiated coagulation. Methods: We extended a previously validated mathematical model of platelet deposition and coagulation under flow to examine polyP-mediated effects after a small vascular injury during intravascular clotting. Simulations varied the surface density of TF exposed, wall shear rate, and plasma TFPIα concentration. Results: Even without direct interaction between polyP and TFPIα in the model, thrombin generation is much less sensitive to TFPIα concentration with polyP, in a TF-dependent manner. Thrombin concentrations are much more robust across the range of physiological shear rates with polyP than without. Incompletely known accelerations by polyP strongly impact relative contributions of accelerations of FV and FXI activations. PolyP shifts the threshold TF density for a thrombin burst to lower TF densities and shortens the lag time to thrombin generation. Conclusions: We identify polyP's effects on blood coagulation beyond acceleration of FV and FXI activation: polyP can produce experimentally-observed TFPIα insensitivity without directly interacting with TFPIα and can improve the robustness of thrombin generation across shear rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.